Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04991831 · ClinicalTrials.gov registry record
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
A clinical trial of Tremor Associated With Tremor Dominant Parkinson's Disease, sponsored by InSightec.
- Recruiting
- Registry status
- 50
- Enrollment target
- 8
- Study locations
NCT04991831: Recruiting study of Tremor Associated With Tremor Dominant Parkinson's Disease, sponsored by InSightec.
NCT04991831 is a study of Tremor Associated With Tremor Dominant Parkinson's Disease that is actively recruiting participants, run by InSightec. The registered enrollment target is 50 participants. The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04991831, a study of Tremor Associated With Tremor Dominant Parkinson's Disease, is actively recruiting participants, sponsored by InSightec.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
Conditions Studied
Interventions
- DEVICE Unilateral thalamotomy
Study Locations (8)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Miami Valley Hospital - Fairborn
Florida
- Miami Neuroscience Institute Baptist Health - Miami
Illinois
- Rush University - Chicago
Massachusetts
- Brigham and Women's Hospital - Boston
New York
- Weill Cornell Medicine - New York
North Carolina
- Novant Health Brain & Spine Surgery - Huntsville
Scotland
- University of Dundee - Dundee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04991831
The ClinicalTrials.gov registry entry for NCT04991831 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tremor Associated With Tremor Dominant Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Unilateral thalamotomy is the first listed.
NCT04991831 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Ohio, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT04991831 about?
NCT04991831 is a clinical study titled "A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease". The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
What is the current status of trial NCT04991831?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-04-28. Estimated completion is 2027-12.
What conditions does trial NCT04991831 study?
This clinical trial studies the following conditions: Tremor Associated With Tremor Dominant Parkinson's Disease.
What interventions are being tested in trial NCT04991831?
The interventions under investigation include: Unilateral thalamotomy (DEVICE).
Who is sponsoring clinical trial NCT04991831?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04991831 being conducted?
This trial has 8 study locations across Florida, Illinois, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.